Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab
July 31, 2014 at 14:30 PM EDT
GlaxoSmithKline plc (NYSE: GSK) and Genmab A/S announced today that an Independent Data Monitoring Committee (IDMC) interim analysis ...
